WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation, a subsidiary of Cytrx Corporation (NASDAQ: CYTR), today announced the appointment of Stephen J. DiPalma as Chief Financial Officer. The Company also announced the planned departure of James Warren to pursue other opportunities.
